Pharmaceuticals & Pharmacy Supplies Wholesaling in Canada - Market Research Report (2014-2029)

Added benefits: Wholesalers will benefit from the advent of new specialty drugs

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.

Pharmacy wholesalers have benefited from its integral role in the pharmaceutical supply chain without the plague of external competition from manufacturers, which is endemic to most wholesale industries. Pharmaceutical wholesalers and self-distributing pharmacy chains, which are excluded from the industry, account for 95.0% of total pharmaceuticals distributed to pharmacies and to long-term and specialized healthcare facilities. Pharmaceuticals have comprised one of the fastest-growing segments of healthcare expenditures over the past two decades. Due to the burgeoning elderly population's sustained need for pharmaceuticals, many downstream markets have sought out wholesalers to provide quick product turnaround. Perpetuating this trend, the uptick of new biologic drugs, particularly cancer and immunosuppressant drugs, has stimulated demand for wholesalers. As a result, industry revenue has been growing at a CAGR of 2.2% over the past five years and is expected to total $80.8 billion in 2023, when revenue will jump by an estimated 1.1%.

The Pharmaceuticals and Pharmacy Supplies Wholesaling industry in Canada distributes medicines, cosmetic products and personal grooming products. This industry does not include manufacturers that sell medicines, equipment and supplies directly to hospitals or doctors’ offices.